Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Researchers from the Japanese National Institute of Infectious Disease have identified the American subtype of Zika as the most virulent for each of the contributing characteristics tested, when compared with Pacific and Southeast Asian subtypes.
An mRNA-based vaccine has been demonstrated to protect against Powassan virus in mice, in addition to also conferring protection against the more distantly related Langat virus.
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
The first citywide deployment of Wolbachia has proved successful, with no dengue cases reported since Wolbachia became established.
A study presented at ECCMID today suggests that in 2017 West Nile virus re-emerged and spread to new areas in Greece, following 2 years with no reported human cases.
A new study has revealed that Zika may not be unique in its ability to cause birth defects, as researchers have identified certain relatives in the family that can also damage developing fetuses in mice.
Learn more about the top news stories of the week in our round-up, including the latest research on influenza, and new findings in MRSA infection.
New research has uncovered that a neuropathogenic virus exploits the neuronal granule system for the transport of viral genomic RNA in dendrites, resulting in reproduction of the virus and severe neurological disease.
New research in macaque models has suggested that prior dengue or yellow fever exposure has no significant effects on subsequent Zika infection in vivo, despite demonstrated enhancement in cell culture.